TOLTERODINE Drug Patent Profile
✉ Email this page to a colleague
When do Tolterodine patents expire, and when can generic versions of Tolterodine launch?
Tolterodine is a drug marketed by Ajanta Pharma Ltd, Aurobindo Pharma Usa, Hetero Labs Ltd Iii, Inventia Hlthcare, Teva Pharms Usa, Torrent, Unichem, Utopic Pharms, Apotex Corp, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Pharmobedient, Rising, and Unique. and is included in sixteen NDAs.
The generic ingredient in TOLTERODINE is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tolterodine
A generic version of TOLTERODINE was approved as tolterodine tartrate by IVAX SUB TEVA PHARMS on February 23rd, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TOLTERODINE?
- What are the global sales for TOLTERODINE?
- What is Average Wholesale Price for TOLTERODINE?
Summary for TOLTERODINE
| US Patents: | 0 |
| Applicants: | 15 |
| NDAs: | 16 |
| Drug Prices: | Drug price information for TOLTERODINE |
| DailyMed Link: | TOLTERODINE at DailyMed |
US Patents and Regulatory Information for TOLTERODINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Unique | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 204721-002 | Jan 24, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Rising | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 210775-002 | Dec 30, 2019 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Unichem | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 205399-001 | Aug 5, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ajanta Pharma Ltd | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 213397-001 | May 19, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Apotex Corp | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 200164-002 | Sep 25, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Macleods Pharms Ltd | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 203409-002 | Aug 31, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
